Former Liverpool and Bournemouth winger Jordon Ibe will appear in court next month, charged with actual bodily harm. The Metropolitan Police said the 30-year-old was arrested at London Luton Airport ...
Former Liverpool winger Jordon Ibe has been fined after admitting to using a fraudulent prescription to obtain sleep medication from a pharmacy. The 30-year-old, who made 41 appearances for Liverpool ...
Former Liverpool winger Jordon Ibe was arrested on suspicion of causing actual bodily harm after stepping off a plane in the UK recently. Ibe, 30, was arrested at Luton Airport on January 30 after ...
FOOTBALL ace Jordon Ibe has been fined £230 for using a forged prescription to obtain sleeping pills at a pharmacy. The ex-Liverpool star, 30, was trying to get his hands on insomnia drug zolpidem.
Jordon Ibe will appear in court charged with actual bodily harm after his arrest at Luton Airport last month, police have said. The former Liverpool winger has been charged in relation to an alleged ...
Editorial Note: We earn a commission from partner links on Forbes Advisor. Commissions do not affect our editors' opinions or evaluations. Disclaimer: Calculator results and default inputs are ...
Jordon Ibe was arrested at Luton Airport on 30 January A footballer has been charged with actual bodily harm in relation to an alleged assault on 14 December. Former AFC Bournemouth player Jordon Ibe, ...
Achieved Positive 4th Quarter 2025 Gross MarginSetting the Stage for 2026 Financial Targets SLINGERLANDS, N.Y., March 02, ...
Former Liverpool winger Jordon Ibe has been sentenced after admitting to using a fraudulent prescription to acquire sleep medication from a pharmacy. The 30-year-old attended Highbury Corner ...
Investing.com -- Iberdrola said on Wednesday it expects earnings growth in 2026 after its networks business in the U.K. and the U.S. helped lift 2025 profit, as the Spanish utility continues to pivot ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.